Differentiation of oncocytoma from chromophobe renal cell carcinoma (RCC): can novel molecular biomarkers help solve an old problem?
about
Genetic and Chromosomal Aberrations and Their Clinical Significance in Renal NeoplasmsRestriction spectrum imaging: An evolving imaging biomarker in prostate MRI.Apparent diffusion coefficient measurement by diffusion weighted magnetic resonance imaging is a useful tool in differentiating renal tumors.Comparison of computed tomography findings between renal oncocytomas and chromophobe renal cell carcinomas.Low-dose gadobenate dimeglumine-enhanced MRI of the kidney for the differential diagnosis of localized renal lesions.The Genomic Landscape of Renal Oncocytoma Identifies a Metabolic Barrier to TumorigenesisExpression of histone methyltransferases as novel biomarkers for renal cell tumor diagnosis and prognostication.Detection of micrometastases by flow cytometry in sentinel lymph nodes from patients with renal tumours.A systematic review and meta-analysis of immunohistochemical biomarkers that differentiate chromophobe renal cell carcinoma from renal oncocytoma.BSND and ATP6V1G3: Novel Immunohistochemical Markers for Chromophobe Renal Cell Carcinoma.An Incidental Renal Oncocytoma: 18F-Choline PET/MRI.Aorta-Lesion-Attenuation-Difference (ALAD) on contrast-enhanced CT: a potential imaging biomarker for differentiating malignant from benign oncocytic neoplasms.Decreased Expression of Inhibitor of Caspase-Activated DNase (ICAD) in Renal Cell Carcinoma - Tissue Microarray of Human Samples.Evaluation of steroid hormones and their receptors in development and progression of renal cell carcinoma.Clinicians' Real World Perceptions of Pre-Nephrectomy Diagnostic Biopsy Performance as a Driver of Reduction in Unnecessary Surgeries in Renal Tumors.
P2860
Q26785930-D428A4B8-6A93-4A7B-8DB8-18ED260951F7Q31121795-46D607FF-9322-45DD-934D-CD23E88FEACDQ35495053-6B2835E5-41B9-427D-BE13-A22D8181A18BQ36177109-384A7176-358A-46FD-8A73-543D7A815FA4Q36285082-E6B5CF82-5414-4A29-AAAD-F7B6BB882439Q36654206-1CC80A0F-1AAB-4C6A-985B-3E63A9C723F4Q36833415-84BF57D7-9646-452E-9FEC-8ACB7EEF28AEQ38748002-8A496591-8AD0-493B-BD3A-2FE5296C012CQ38763962-2B08410F-E643-487C-9649-4A0D723752E4Q40819839-AAF33345-F81C-4B26-A664-909B68F53A20Q46804547-D1376EF4-B54D-4B35-BC00-A3BBDFA8D8E8Q48236597-4B2FD49B-6D66-49F3-8126-269E8C9B4830Q51091486-30D6CFF8-EFF8-4FDF-B4E1-21C246725DE2Q53733289-879D2F3A-0630-4607-9142-70C94240E009Q54306744-AD2A2F53-2EE5-46DC-8695-C429898ADE9C
P2860
Differentiation of oncocytoma from chromophobe renal cell carcinoma (RCC): can novel molecular biomarkers help solve an old problem?
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Differentiation of oncocytoma ...... ers help solve an old problem?
@en
type
label
Differentiation of oncocytoma ...... ers help solve an old problem?
@en
prefLabel
Differentiation of oncocytoma ...... ers help solve an old problem?
@en
P2093
P2860
P50
P1476
Differentiation of oncocytoma ...... ers help solve an old problem?
@en
P2093
Glenda C Gobe
Keng Lim Ng
Ning Yi Yap
Simon T Wood
P2860
P304
P356
10.1136/JCLINPATH-2013-201895
P407
P577
2013-10-29T00:00:00Z